Business Wire

Adtran accelerates broadband rollouts with market’s most scalable fiber access platform

24.1.2023 18:12:00 EET | Business Wire | Press release

Share

Adtran®, Inc., (NASDAQ:ADTN), the leading provider of next-generation open and disaggregated networking solutions, today launched its SDX 6330 10Gbit/s Combo PON fiber access platform, enabling service providers to rapidly and cost-effectively connect homes and businesses with fiber-based broadband. The new open and disaggregated solution offers the industry’s highest port density and is the first optical line terminal (OLT) with integrated 400Gbit/s uplinks. It will empower operators to accelerate fiber rollout and easily scale their networks to support dense urban, suburban and rural deployments. With enhanced energy efficiency, the highly compact, temperature-hardened fiber access platform will be important to meeting sustainability targets and addressing market demands for both retail and wholesale providers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230124005747/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Adtran’s SDX 6330 will help service providers meet subscriber demand in the most scalable and sustainable way possible. (Photo: Business Wire)

“Service providers face a tough environment as they strive to keep up with growing subscriber needs, expand coverage and meet green targets. With households and businesses accessing more and more data-hungry applications, operators need strategies in place to handle the surge in a cost-effective and sustainable way. This challenge is precisely what our third-generation fiber access platform aims to address,” said Robert Conger, SVP of technology and strategy at Adtran. “Our SDX 6330 offers the network simplicity, sustainability and scalability needed to power the Gigabit Society. That’s what makes it a compelling alternative to chassis-based architectures. It’s the solution many operators are searching for as they look to expand their market share while improving customer experience.”

The SDX 6330 is Adtran’s third generation of open and disaggregated OLT devices. With 48 ports of Combo PON in a compact and power-efficient design, it sets a new benchmark for lowering the total cost of deployment for 10Gbit/s services. Designed to deliver network simplicity and sustainability at scale, the solution offers deployment versatility and improved reach. Featuring open interfaces, it provides freedom to build best-in-class infrastructure with technology from multiple vendors, and its versatile architecture supports a wide range of network topologies and coherent optics. The SDX 6330 also helps meet corporate sustainability objectives by reducing power demand and landfill requirements.

“Our SDX 6330 is the most advanced fiber access platform in the industry, and the impact it’s about to have will be significant. By empowering service providers to reduce both the time and cost of getting people connected, we’re going to see broadband coverage increase like never before,” commented Ronan Kelly, CTO for EMEA and APAC at Adtran. “As pioneers in open and disaggregated fiber access innovation, we’ve consistently pushed boundaries, beginning with our industry-first deployments dating back to 2017. Now with our third-generation device, we’re taking density and scalability to new heights. Our SDX 6330 will transform networks into flexible, multigigabit service delivery platforms, empowering operators to stay ahead of the bandwidth consumption curve.”

About Adtran

Adtran, Inc. is a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. Adtran, Inc. is a wholly-owned subsidiary of ADTRAN Holdings, Inc. (NASDAQ:ADTN and FSE: QH9). Find more at Adtran, LinkedIn and Twitter.

Published by
Adtran, Inc.
www.adtran.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For media
Gareth Spence
t +44 1904 699 358
public-relations@adva.com

For investors
Rhonda Lambert
t +1 256-963-7450
investor@adtran.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Experian's New Documentary RECLAIM Shows How Financial Access and Innovation Are Creating Opportunity Around the World5.11.2026 17:00:00 EET | Press release

For years, Almir dreamed of meeting his granddaughter in the United States. But unresolved debt stood in the way. Thousands of miles away in Arizona, Elizabeth faced mounting medical expenses after a health crisis. In London, Rochelle worked to regain control of her finances while caring for family members. Their stories, and others like them, are at the heart of RECLAIM: Stories of Passion and Perseverance, a new documentary from global technology and data company Experian that explores how access to financial tools, technology and support can help people overcome obstacles and pursue new opportunities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105341861/en/ Behind-the-scenes photo from the filming of RECLAIM: Stories of Passion and Perseverance, an Experian documentary. Brody Frye, who received care from The MetroHealth System in Cleveland, Ohio, is featured in the film’s story about healthcare innovation and the p

Saudi Fund for Development Signs Six Development Loan Agreements Worth Over USD 403 Million with Syria5.11.2026 16:32:00 EET | Press release

The Saudi Fund for Development (SFD) has signed six concessional development loan agreements worth more than USD 403 million with the Syrian Arab Republic, marking a significant step in supporting the country’s recovery through the rehabilitation of essential infrastructure, restoration of vital public services and improvement of living conditions for communities affected by years of conflict. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105350224/en/ HRH the Crown Prince and President of the Syrian Arab Republic Al-Sharaa witness signing of agreements (Photo: AETOSWire The agreements, signed under the directives of the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud, and His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister, reflect the Kingdom’s continued commitment to supporting Syria’s development priorities. The signing ceremony was witnessed by Hi

LPs Expect Private Markets Managers to Level Up in 2027: SS&C Intralinks Survey5.11.2026 16:00:00 EET | Press release

SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced the publication of the 2027 LP Survey. In association with Reuters Insights, SS&C Intralinks surveyed 400 professionals working in private markets, including 370 limited partners and allocators, to understand how the alternative investments market will change in the next 12 months.* “Alternatives once again delivered in 2026, and LPs are still committing capital, but their expectations of managers continue to rise,” said Ken Bisconti, general manager of SS&C Intralinks. “Technology and data capabilities now rank among the most important criteria for selecting managers, alongside investment strategy. Performance alone is no longer enough. For nearly one-third of allocators, a credible artificial intelligence (AI) strategy is now a prerequisite for allocating capital to a manager.” Key findings from the report include: Alternatives portfolios continue to outperform. 62% of respondents said their portfolios exceeded expectati

Hyperice Unveils Normatec Elite Heat Legs: Integrated Heat Meets Dynamic Air Compression in a New Fully Wireless Design5.11.2026 16:00:00 EET | Press release

Hyperice, a high-performance wellness brand, today announced the launch of Normatec Elite Heat Legs, the newest innovation in the award-winning Normatec line and the first Normatec product to incorporate heat directly into its line of dynamic air compression therapy. As the 2024 launch of Normatec Elite signified a transformative leap forward in recovery technology, Elite Heat demonstrates Hyperice’s relentless commitment to offering athletes and wellness enthusiasts alike the most comprehensive and intuitive recovery experiences in the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105782891/en/ Normatec Elite Heat demonstrates Hyperice’s relentless commitment to offering athletes and wellness enthusiasts alike the most comprehensive and intuitive recovery experiences in the world. “Innovation has always been at the forefront of everything we do,” said Jim Huether, CEO of Hyperice. “Heat and dynamic air compressio

European Commission expands license for Alfasigma’s Jyseleca ® (filgotinib) with approval of new indication, treatment of adults with axial spondylarthritis5.11.2026 16:00:00 EET | Press release

The information contained within this press release is for the purpose of scientific exchange. It is intended for scientific, financial and investor media only. Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Commission (EC) has approved an additional indication to Jyseleca® (filgotinib) 200 mg and 100 mg film-coated tablets, an oral once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. A submission for UK approval has been made to the Medicines and Healthcare products Regulatory Agency (MHRA) and is under review. The European Commission’s approval is based on data that support a favourable benefit-risk profile for filgotinib, including efficacy and safety fin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye